Intravitreal Infliximab may be used in treatment of noninfectious uveitis. It probably improves the vision and decreases the macular edema but its effect is temporary and repeated injections may be needed to achieve the best therapeutic goal.

Positive ABT indicated no anatomical failure after Ext-DCR in this series.

No abstract

All anatomically failed DCR showed a positive FDDT (100% sensitivity) in this series. The proposed paradigm offers a less invasive approach to post-DCR epiphora.